Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA)

81 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q4 2021.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,168,410 shares of 96,015,846 outstanding shares and own 18.92% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (2,541,645 shares), 5AM Venture Management, LLC (2,064,263 shares), CITADEL ADVISORS LLC (1,499,623 shares), SAMLYN CAPITAL, LLC (1,383,381 shares), Cormorant Asset Management, LP (1,154,424 shares), Ikarian Capital, LLC (970,398 shares), Point72 Asset Management, L.P. (950,000 shares), VANGUARD GROUP INC (904,492 shares), Redmile Group, LLC (696,377 shares), and BAKER BROS. ADVISORS LP (662,063 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.